COY ALLEN: Open Payments
NPI 1346992401 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 17 payments from 10 companies in 2025. Trend: 2023 $407 · 2024 $869 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $142 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Corcept Therapeutics | 2 | $55 |
| Lilly USA, LLC | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: REPATHA, TRELEGY ELLIPTA, Korlym, AMYVID, OTEZLA, VOQUEZNA, YUPELRI, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
